Frontier IP Group PLC

Frontier IP investee company achieves major milestone in GSK collaboration

Exscientia has delivered a lead molecule using artificial intelligence

Using AI proved more efficient than traditional screening methods

Frontier IP PLC (LON:FIPP) shares rose on Thursday as the firm said its investee company Exscientia has reached its first major milestone in its collaboration with drugs giant GlaxoSmithKline PLC (LON:GSK) by delivering a lead molecule identified using artificial intelligence.

The drug candidate will target chronic obstructive pulmonary disease, which affects 384mln people globally.

READ: Frontier IP shares lifted as portfolio value jumps 27% in first half

Using the Centaur Chemist AI platform, researchers were able to cut the number of candidate molecules screened when compared with traditional drug discovery methods.

Andy Bell, chief research officer of Exscientia, said: "Our AI platform and approach have advanced significantly over the past few years and have been constantly refined and optimised through real-world projects for our pharma partners.

“With the productivity improvements we are now seeing, we believe that our Centaur Chemist approach is proving itself to be the industry's leading AI-drug discovery platform by achieving far superior results to what conventional discovery techniques have historically delivered."

Frontier IP, which specialises in commercialising university intellectual property, has a 3.32% stake in the drug discovery group.

In afternoon trading, shares in Frontier IP were 3.6% higher at 86p.

 -- Adds share price --

Quick facts: Frontier IP Group PLC

Price: 64.74 GBX

Market: AIM
Market Cap: £33.03 m


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Frontier IP Group PLC named herein, including the promotion by the Company of Frontier IP Group PLC in any Content on the Site, the Company...



Frontier IP Group 'well positioned for another positive performance'

Frontier IP Group PLC's (LON:FIPP) Neil Crabb tells Proactive London's Andrew Scott he's confident their portfolio will continue to grow after profits in its latest full-year increased 160%. The fair value of the group’s investment portfolio also increased by 47% to £13.25mln, while it ended...

on 8/11/19


Holding(s) in Company

3 hours, 49 minutes ago

Holding(s) in Company

3 hours, 53 minutes ago

Holding(s) in Company

5 hours, 6 minutes ago

Holding(s) in Company

9 hours, 28 minutes ago

Grant of Options

12 hours, 14 minutes ago

Holding(s) in Company

4 days, 7 hours ago

2 min read